| Literature DB >> 26941790 |
Bayu Lestari1, Nur Permatasari2, Mohammad Saifur Rohman3.
Abstract
The increase of heart failure prevalence on menopausal women was correlated with the decrease of estrogen level. The aim of this study is to investigate the effects of ceplukan leaf (Physalis minima L.), which contains phytoestrogen physalin and withanolides, on ventricular TNF-α level and fibrosis in ovariectomized rats. Wistar rats were divided into six groups (control (-); OVX 5: 5-week ovariectomy (OVX); OVX 9: 9-week ovariectomy; treatments I, II, and III: 9-weeks OVX + 4-week ceplukan leaf's methanolic extract doses 500, 1500, and 2500 mg/kgBW, resp.). TNF-α levels were measured with ELISA. Fibrosis was counted as blue colored tissues percentage using Masson's Trichrome staining. This study showed that prolonged hypoestrogen increases ventricular fibrosis (p < 0.05). Ceplukan leaf treatment also resulted in a decrease of ventricular fibrosis and TNF-α level in dose dependent manner compared to without treatment group (p < 0.05). Furthermore, the TNF-α level was normalized in 2500 mg/kgBW Physalis minima L. (p < 0.05) treatment. The reduction of fibrosis positively correlated with TNF-α level (p < 0.05, r = 0.873). Methanolic extract of ceplukan leaf decreases ventricular fibrosis through the inhibition of ventricular TNF-α level in ovariectomized rats.Entities:
Year: 2016 PMID: 26941790 PMCID: PMC4752972 DOI: 10.1155/2016/2428052
Source DB: PubMed Journal: Adv Pharmacol Sci ISSN: 1687-6334
Measurements of heart morphometric.
| Parameters | Control (—) | OVX 5 | OVX 9 | Treatment I | Treatment II | Treatment III | ANOVA |
|---|---|---|---|---|---|---|---|
| BW (gram) | 236.5 ± 14.2 | 280.8 ± 33.4 | 264.3 ± 20.0 | 237.0 ± 19.9 | 250.8 ± 16.5 | 252.5 ± 34.6 | 0.124 |
| LVW (mg) | 501 ± 16.2 | 578.8 ± 54.6# | 547 ± 41.6 | 502.6 ± 25.1 | 519.2 ± 40.3 | 514.5 ± 30.8 | 0.026 |
| RVW (mg) | 127 ± 15.6 | 136.6 ± 22.0 | 119.7 ± 16.9 | 125.4 ± 24.9 | 121.8 ± 16.9 | 119.3 ± 8.3 | 0.706 |
| AW (mg) | 82.9 ± 3.4 | 88.9 ± 10.0 | 81.5 ± 5.05 | 88.8 ± 2.9 | 84.4 ± 5.5 | 80.3 ± 1.7 | 0.174 |
| LVW/HW ratio | 0.705 | 0.720 | 0.731 | 0.704 | 0.716 | 0.720 | 0.298 |
| HW/BW ratio | 3.01 × 10−3 | 2.87 × 10−3 | 2.85 × 10−3 | 3.03 × 10−3 | 2.90 × 10−3 | 2.85 × 10−3 | 0.757 |
Statistical analysis for body weight using Kruskal-Wallis test as post hoc test. p < 0.05 using one-way ANOVA analysis. # p < 0.05 compared with control (—) using Tukey's test as post hoc test.
BW: body weight; LVW: left ventricular weight; RVW: right ventricular weight; AW: atrial weight; OVX 5: 5-week ovariectomy; OVX 9: 9-week ovariectomy; Treatments I, II, and III: 9-week ovariectomy with 500, 1500, and 2500 mg/kgBW ceplukan leaf's methanolic extract, respectively.
Figure 1Mean of ventricular TNF-α level in each group (pg/mL). a p < 0.05 compared to control (—) group and treatment groups; b p < 0.05 compared to control (—) and OVX groups; c p < 0.05 compared to OVX groups. OVX 5: 5-week ovariectomy; OVX 9: 9-week ovariectomy. Treatments I, II, and III reflected 9-week ovariectomy treated with 500, 1500, and 2500 mg/kgBW ceplukan leaf's methanolic extract, respectively.
Figure 2Masson's Trichrome staining of ventricular histologic preparation (ocular magnification 4x). Blue color indicates ventricular fibrosis (marked with white arrows).
Figure 3Mean of ventricular fibrosis in each group (%). a p < 0.05 compared to control (—), OVX 9, treatment III groups; b p < 0.05 compared to all other groups; c p < 0.05 compared to control (—) and OVX 9; d p < 0.05 compared to OVX and control (—). OVX 5: 5-week ovariectomy; OVX 9: 9-week ovariectomy. Treatments I, II, and III reflected 9-week ovariectomy treated with 500, 1500, and 2500 mg/kgBW ceplukan leaf's methanolic extract, respectively.